Literature DB >> 31180501

Tbx1 regulates extracellular matrix-cell interactions in the second heart field.

Daniela Alfano1, Alessandra Altomonte1, Claudio Cortes2, Marchesa Bilio1, Robert G Kelly2, Antonio Baldini1,3.   

Abstract

Tbx1, the major candidate gene for DiGeorge or 22q11.2 deletion syndrome, is required for efficient incorporation of cardiac progenitors of the second heart field (SHF) into the heart. However, the mechanisms by which TBX1 regulates this process are still unclear. Here, we have used two independent models, mouse embryos and cultured cells, to define the role of TBX1 in establishing morphological and dynamic characteristics of SHF in the mouse. We found that loss of TBX1 impairs extracellular matrix (ECM)-integrin-focal adhesion (FA) signaling in both models. Mosaic analysis in embryos suggested that this function is non-cell autonomous, and, in cultured cells, loss of TBX1 impairs cell migration and FAs. Additionally, we found that ECM-mediated integrin signaling is disrupted upon loss of TBX1. Finally, we show that interfering with the ECM-integrin-FA axis between E8.5 and E9.5 in mouse embryos, corresponding to the time window within which TBX1 is required in the SHF, causes outflow tract dysmorphogenesis. Our results demonstrate that TBX1 is required to maintain the integrity of ECM-cell interactions in the SHF and that this interaction is critical for cardiac outflow tract development. More broadly, our data identifies a novel TBX1 downstream pathway as an important player in SHF tissue architecture and cardiac morphogenesis.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31180501     DOI: 10.1093/hmg/ddz058

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

Review 1.  Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.

Authors:  Pratibha Bhalla; Christian A Wysocki; Nicolai S C van Oers
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

2.  Positively selected genes in the hoary bat (Lasiurus cinereus) lineage: prominence of thymus expression, immune and metabolic function, and regions of ancient synteny.

Authors:  Robert S Cornman; Paul M Cryan
Journal:  PeerJ       Date:  2022-03-17       Impact factor: 2.984

3.  A phenotypic rescue approach identifies lineage regionalization defects in a mouse model of DiGeorge syndrome.

Authors:  Gabriella Lania; Monica Franzese; Noritaka Adachi; Marchesa Bilio; Gemma Flore; Annalaura Russo; Erika D'Agostino; Claudia Angelini; Robert G Kelly; Antonio Baldini
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

Review 4.  Control of cardiomyocyte differentiation timing by intercellular signaling pathways.

Authors:  Megan Rowton; Alexander Guzzetta; Ariel B Rydeen; Ivan P Moskowitz
Journal:  Semin Cell Dev Biol       Date:  2021-06-16       Impact factor: 7.727

5.  Cell-Extracellular Matrix Interactions Play Multiple Essential Roles in Aortic Arch Development.

Authors:  Michael Warkala; Dongying Chen; AnnJosette Ramirez; Ali Jubran; Xia Wang; Michael Schonning; Huaning Zhao; Sophie Astrof
Journal:  Circ Res       Date:  2020-11-30       Impact factor: 17.367

6.  TBX1 and Basal Cell Carcinoma: Expression and Interactions with Gli2 and Dvl2 Signaling.

Authors:  Cinzia Caprio; Silvia Varricchio; Marchesa Bilio; Federica Feo; Rosa Ferrentino; Daniela Russo; Stefania Staibano; Daniela Alfano; Caterina Missero; Gennaro Ilardi; Antonio Baldini
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

7.  Essential role of the Crk family-dosage in DiGeorge-like anomaly and metabolic homeostasis.

Authors:  Akira Imamoto; Sewon Ki; Leiming Li; Kazunari Iwamoto; Venkat Maruthamuthu; John Devany; Ocean Lu; Tomomi Kanazawa; Suxiang Zhang; Takuji Yamada; Akiyoshi Hirayama; Shinji Fukuda; Yutaka Suzuki; Mariko Okada
Journal:  Life Sci Alliance       Date:  2020-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.